IGC Pharma, Inc.IGCNYSE
Loading
Year-over-year operating cash flow growth rate
Percentile
P31
Within normal range
vs 5Y Ago
-1.3x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | -48.54% |
| Q2 2025 | -92.74% |
| Q1 2025 | 44.57% |
| Q4 2024 | -32.23% |
| Q3 2024 | 43.15% |
| Q2 2024 | -233.08% |
| Q1 2024 | 66.86% |
| Q4 2023 | 1.92% |
| Q3 2023 | -10.22% |
| Q2 2023 | 3.23% |
| Q1 2023 | 7.95% |
| Q4 2022 | 2.25% |
| Q3 2022 | 23.22% |
| Q2 2022 | -147.58% |
| Q1 2022 | 63.38% |
| Q4 2021 | -5.21% |
| Q3 2021 | -24.37% |
| Q2 2021 | 26.11% |
| Q1 2021 | -35.77% |
| Q4 2020 | 25.06% |
| Q3 2020 | 38.26% |
| Q2 2020 | -100.10% |
| Q1 2020 | 11.03% |
| Q4 2019 | -42.49% |
| Q3 2019 | 45.26% |
| Q2 2019 | -150.17% |
| Q1 2019 | 13.75% |
| Q4 2018 | -320.92% |
| Q3 2018 | 40.87% |
| Q2 2018 | 44.16% |
| Q1 2018 | -176.95% |
| Q4 2017 | -227.55% |
| Q3 2017 | 79.77% |
| Q2 2017 | 42.52% |
| Q1 2017 | -568.74% |
| Q4 2016 | 122.02% |
| Q3 2016 | -533.51% |
| Q2 2016 | 226.07% |
| Q1 2016 | -3842.08% |
| Q4 2015 | -100.73% |